Metastatic Castration-Resistant Prostate Carcinoma
Oncology·MeSH: Prostatic Neoplasms
2 drugs in development·2 companies·3 clinical trials
Drug Pipeline by Phase
Phase 1(1)
| Drug | Company |
|---|---|
| Avelumab | Accustem Sciences Inc. (ACUT) |
Phase 4(1)
Compare drugs
Frequently asked questions
How many drugs are in development for Metastatic Castration-Resistant Prostate Carcinoma?
BioSniper tracks 2 drugs in development for Metastatic Castration-Resistant Prostate Carcinoma across 2 companies.
How many clinical trials target Metastatic Castration-Resistant Prostate Carcinoma?
There are 3 clinical trials targeting Metastatic Castration-Resistant Prostate Carcinoma tracked by BioSniper.
Deep-dive into Metastatic Castration-Resistant Prostate Carcinoma
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis